Evotec SE Files 6-K Report

Ticker: EVO · Form: 6-K · Filed: Apr 24, 2026 · CIK: 0001412558

Sentiment: neutral

Topics: foreign-issuer, regulatory-filing, pharmaceuticals

TL;DR

Evotec SE dropped a 6-K filing on 4/24/26. Routine update.

AI Summary

Evotec SE filed a Form 6-K on April 24, 2026, reporting information as a foreign issuer. The filing includes the main 6-K document and exhibits, with the company's mailing and business addresses listed as ESSENER BOGEN 7, HAMBURG, Germany. The filing is related to its operations in the pharmaceutical preparations sector.

Why It Matters

This filing provides routine updates for Evotec SE as a foreign issuer, offering transparency to investors about its ongoing corporate activities and regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine foreign issuer filing (6-K) and does not appear to contain significant new financial or strategic information.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign issuer required by the SEC, used to furnish information which the issuer makes or is required to make public pursuant to the laws of the issuer's home country or the country in which it is incorporated or organized, or files or is required to file with a stock exchange on which the securities are traded.

When was this specific Form 6-K filed by Evotec SE?

This Form 6-K was filed on April 24, 2026.

What are the business and mailing addresses for Evotec SE as listed in the filing?

The business and mailing addresses for Evotec SE are both listed as ESSENER BOGEN 7, HAMBURG, Germany, 22419.

What is the CIK number associated with Evotec SE in this filing?

The CIK number for Evotec SE is 0001412558.

What SIC code is listed for Evotec SE?

The SIC code listed for Evotec SE is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 24, 2026 regarding Evotec SE (EVO).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing